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ABSTRACT 
 
 
The outcome of the Michael-type reaction between thiols and 2,2-disubstituted cyclopentenediones varies 
depending on the thiol. Stable compounds with two fused rings were formed upon reaction with 1,2-aminothiols 
(such as N-terminal cysteines in peptides). Other thiols  gave reversibly Michael-type adducts that were in 
equilibrium with the starting materials. This differential reactivity allows differently placed cysteines to be 
distinguished, and has been exploited to prepare bioconjugates incorporating two or three different moieties. 
The Michael-type addition of a thiol to a maleimide is 
the thiol-involving click reaction most frequently 
exploited for bioconjugation.1 It is water-compatible, 
quick and clean, and takes place in high yield without 
the need of any catalyst. Yet, it has recently been found 
that the resulting Michael-type adducts (MTAs) may 
undergo thiol exchange and hydrolysis to an extent 
depending on both the nature of the maleimide and the 
environment.2 Thiol exchange may cause premature loss 
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of payload from therapeutically relevant compounds 
such as antibody-drug conjugates,3 and as a result of 
hydrolysis conjugates may lose their structural integrity 
and become a mixture of products. 
Since thiols are natural components of peptides and 
proteins, several groups are actively searching for new 
thiol-involving conjugation methods providing stable 
linkages.4 
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2,2-Disubstituted cyclopent-4-ene-1,3-diones (CPDs), 
which formally differ from N-substituted maleimides in 
that the N-alkyl group is replaced by a dialkylated 
carbon, hold promise for conjugation purposes because 
the MTAs resulting from reaction with thiols cannot be 
hydrolyzed. Although the homologue of acid 2 (see 
below) and N-acetylcysteine reacted to give a stable 
MTA as a mixture of four stereoisomers,5 2,2,4,5-
tetramethyl-cyclopent-4-ene-1,3-dione failed to form 
thiol adducts with N-acetylcysteamine.6 
Here we investigate the reaction of CPDs with 
cysteine-containing compounds, and their potential in 
the preparation of bioconjugates. We have found that the 
outcome of the Cys-CPD reaction varies depending on 
the position of the cysteine residue within peptide (or, in 
general, polyamide) chains. 
Four CPDs differing in one of the C2 substituents (1-
4, Figure 1) were prepared (see the Supporting 
Information, section 2). 
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Figure 1. Synthesized CPDs. 
 
First experiments aimed to examine the effect of 
cysteine position within peptide chains on the Cys-CPD 
reaction. Therefore peptides H-WGRGC-NH2 (5), H-
KYAYCG-NH2 (6) and H-CYG-NH2 (7) were reacted 
with CPDs 1 or 2 (water, 37 oC, Scheme 1 and 
Supporting Information, sections 3 and 4), and the 
reaction progress was monitored by HPLC. 
In reactions involving 5 and 6 it was observed that 
peptides were not fully consumed in spite of the 
presence of an excess of CPD (5 equiv) in the mixture, 
and that amount of the MTAs in the crude decreased as 
the unreacted peptide underwent oxidation to the 
disulfide dimer. Isolated MTAs (8 and 9, respectively) 
were found to revert to the parent CPD and peptide after 
60 min incubation in water. These results differ from 
previously described ones5 and from formation of the 
MTA upon reacting N-acetylcysteine and 2,4,5-
tetramethyl-cyclopent-4-ene-1,3-dione (though in 15% 
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yield6). In contrast to their maleimide counterparts,7 
Michael additions to cyclopent-4-ene-1,3-diones may be 
reversible. 
DFT calculations showed that maleimide-thiol MTAs 
have a greater stability than CPD-thiol MTAs 
(Supporting Information, sections 12 and 13), which is 
in agreement with the equilibria observed in the 
experiments reported here. 
 
Scheme 1. Reaction of CPDs with different thiols. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mass corresponding to the Michael-type adduct of 
7 + 1 (Scheme 1b) was not observed. Instead, when the 
reaction was monitored by HPLC/MS it was observed 
that two new products with masses 18 and 20 Da lower 
were formed, and that the one with the M-18 Da mass 
(10) evolved into the final, stable compound whose mass 
was M-20 Da (11). We thus surmised that the Michael-
type adduct very quickly underwent intramolecular 
imine formation to generate a 6-membered ring, which 
would account for the presence of the M-18 Da 
compound 10 in the reaction mixture. Subsequent loss of 
two H atoms would render the oxidized M-20 Da adduct 
11.8  
Intramolecular cyclization to form an imine-
containing six-membered ring is not unknown, and 
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occurs when cysteine reacts with α-bromoketones.9 In 
our case, the presence of the carbonyl group in the five-
membered ring likely favors the unprecedented 
subsequent oxidation, which yields the CO-C=C-C=N 
conjugated system. The UV-vis spectrum of the M-20 
Da adducts exhibits a maximum around 330 nm, which 
is consistent with such a conjugated structure. 
To confirm the structure of the M-20 Da adduct, CPD 
1 was reacted with methyl cysteinate (which mimicked a 
peptide containing an N-terminal cysteine), and the final 
adduct (13, Scheme 1b) was isolated and characterized 
by NMR (1H, 13C, gHSQC) and electrospray HRMS. 
This proved that 13 is a 4,7,7-trisubstituted 2-thia-5-aza-
bicyclo[4.3.0]nona-1(9),5-diene-8-one (see Supporting 
Information, section 9.3, for an assessment of the 
stability of these adducts).  
Methyl cysteinate was also reacted with CPDs 2, 3 
and 4 (Supporting Information, section 5). The evolution 
of the reaction was the same as with CPD 1. Initially 
formed M-18 Da adducts (14, 16, 18) evolved into the 
M-20 Da ones (15, 17 and 19, respectively), which 
proves that the reaction outcome is independent of the 
CPD substituents at the 2 position.  
In all previous experiments we had perceived that the 
M-18 Da to M-20 Da adduct oxidation was the rate-
limiting step. Upon reacting methyl cysteinate and 2 
under different conditions (Supporting Information, 
section 6), it was found that the 14 to 15 conversion 
rate increased with temperature, and decreased when 
water was replaced by 1:1 mixtures of water and an 
organic co-solvent (the conversion rate was higher 
using dimethylsulfoxide than using methanol or 
acetonitrile). It was also found that use of an excess 
of CPD increased the 14 to 15 conversion rate, but not 
the use of an excess of the thiol component. 
In the case of the 1 + cysteine reaction, the M-20 Da 
adduct (21) underwent reversible hydrolysis of the imine 
to yield an M-2 Da zwitterionic compound (22, see 
Supporting Information, section 7).  
Homocysteine (Hcy) was also included in this study 
because of its biological relevance in cardiovascular and 
neurological pathologies.10 It has been reported that Cys 
and Hcy can react with the same compound, generally at 
different rates, to generate homologous structures 
differing in only one methylene.4a,11 However, as in 
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reactions involving N-acylated 1,2-aminothiols the M-20 
Da and M-18 Da adducts were not detected, and only the 
MTA (23) was formed (Supporting Information, section 
8). The isolated MTA reverted to the parent compounds. 
DFT Calculations (Supporting Information, section 12) 
confirmed that the energy barriers of the first two steps 
leading to imine formation (7-membered ring) are higher 
for Hcy than for H-Cys-OH or H-Cys-OMe. This 
discrimination provides a basis on which separation 
and/or detection systems could be devised. 
 
Scheme 2. Synthesis of Cys-CPD conjugates.12 
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At this point it was time to assess whether the Cys-
CPD reaction could be of use to prepare conjugates. It 
was first verified that CPD 2 can be attached to resin-
linked peptide and peptide nucleic acid (PNA) chains, 
and the corresponding CPD-polyamides 24a-c be 
obtained after the trifluoroacetic acid-mediated 
deprotection reaction (Scheme 2). Then, peptide 24a was 
reacted with the cysteine-derivatized PNA 25d, and 
PNA 24c with peptide 25e. Peptide-oligonucleotide 
conjugates were also synthesized by reacting peptides 
24a and 24b with cysteine-derivatized oligonucleotides 
(25f-25h) prepared following described procedures.13 In 
all cases the target conjugates 26 were satisfactorily 
obtained (2-5 h reaction times). 
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Since the outcome of the reaction between CPDs and 
cysteines differs depending on whether the amine is free 
or acylated, we decided to investigate the possibility of 
selectively labeling N-terminal cysteines in the presence 
of differently placed cysteines, which is not straight-
forward. Aldehydes14 and 2-cyanobenzothiazoles4a are 
among the few reagents that react selectively with N-
terminal cysteines. In the other cases, even though it has 
been shown that local environment may affect cysteine 
reactivity and render them chemically distinguishable,15 
regioselectivity is typically difficult to achieve unless 
cysteines are orthogonally protected.  
In a preliminary experiment, CPD 2 was incubated 
with a 1:1 mixture of peptides 6 (H-KYAYCG-NH2) and 
H-CSYAKYG-NH2 (25e) (Supporting Information, 
section 10). As expected from previous experiments, 
HPLC/MS analysis of the reaction mixture showed that 
25e had reacted completely (yielding M-20 Da adducts 
27), whereas 6 had not at all. This result confirmed that 
N-terminal cysteines could be selectively labeled in the 
presence of peptides with cysteines at internal positions.  
Next, peptide H-CSYACKYG-NH2 (28) was reacted 
with two model alkylating agents, namely CPD 2 and 3-
maleimidopropanoic acid (Scheme 3). The peptide was 
first incubated with 2 (1.1 equiv). After 90 min reaction 
time, 3-maleimidopropanoic acid (5 equiv) was added. 
HPLC/MS Analysis of the crude 1 h later showed the 
presence of two new peaks (see Figure S38) whose mass 
fitted with that of the doubly derivatized peptide (29a). 
A similar procedure was used to prepare conjugates (29b 
and 29c, Scheme 3) assembling three different moieties, 
namely a peptide (H-CWGRGC-NH2, 30), a PNA (24c 
or 31) and a tagging agent (either biotin or a 
fluorophore). These results, as well as those summarized 
in Scheme 2, prove that formation of the M-20 Da 
adduct takes place irrespective of the moiety linked to 
the cysteine carboxyl group. 
To sum up, this piece of work has revealed that 2,2-
disubstituted cyclopent-4-ene-1,3-diones (CPDs) react 
differently from maleimides, even though CPDs can be 
formally considered maleimide mimics. Strikingly, the 
outcome of the reaction between CPDs and cysteines 
whose amine is free (1,2-aminothiols) differs from that 
of the reactions involving N-acylated cysteines and Hcy. 
Only the former react irreversibly with CPDs giving 
water-stable bicyclic nonadienone adducts that can be 
exploited for bioconjugation. In the other cases the 
Michael-type adducts (MTAs) revert to the starting 
materials. The different behavior of maleimides and 
cyclopentenediones is reproduced by DFT calculations. 
CPDs also distinguish N-terminal cysteines from 
cysteines placed at different positions, thus pointing to 
new alternatives for the regioselective derivatization of 
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peptides and proteins, to which N-terminal cysteines can 
be added for conjugation purposes.4a,16 The reaction 
between CPDs and cysteines with a free amine has been 
successfully exploited to prepare a variety of conjugates, 
both incorporating two and three different components. 
 
Scheme 3. Double derivatization experiments. 
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